1. Home
  2. AVTX vs ASRV Comparison

AVTX vs ASRV Comparison

Compare AVTX & ASRV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVTX
  • ASRV
  • Stock Information
  • Founded
  • AVTX 2011
  • ASRV 1983
  • Country
  • AVTX United States
  • ASRV United States
  • Employees
  • AVTX N/A
  • ASRV N/A
  • Industry
  • AVTX Biotechnology: Pharmaceutical Preparations
  • ASRV Major Banks
  • Sector
  • AVTX Health Care
  • ASRV Finance
  • Exchange
  • AVTX Nasdaq
  • ASRV Nasdaq
  • Market Cap
  • AVTX 57.4M
  • ASRV 51.0M
  • IPO Year
  • AVTX 2015
  • ASRV N/A
  • Fundamental
  • Price
  • AVTX $7.89
  • ASRV $2.93
  • Analyst Decision
  • AVTX Strong Buy
  • ASRV
  • Analyst Count
  • AVTX 7
  • ASRV 0
  • Target Price
  • AVTX $31.00
  • ASRV N/A
  • AVG Volume (30 Days)
  • AVTX 149.3K
  • ASRV 28.5K
  • Earning Date
  • AVTX 08-11-2025
  • ASRV 07-22-2025
  • Dividend Yield
  • AVTX N/A
  • ASRV 4.10%
  • EPS Growth
  • AVTX N/A
  • ASRV N/A
  • EPS
  • AVTX N/A
  • ASRV 0.22
  • Revenue
  • AVTX $441,000.00
  • ASRV $51,581,000.00
  • Revenue This Year
  • AVTX N/A
  • ASRV N/A
  • Revenue Next Year
  • AVTX N/A
  • ASRV N/A
  • P/E Ratio
  • AVTX $1.17
  • ASRV $13.29
  • Revenue Growth
  • AVTX N/A
  • ASRV 13.95
  • 52 Week Low
  • AVTX $3.39
  • ASRV $2.03
  • 52 Week High
  • AVTX $16.00
  • ASRV $3.42
  • Technical
  • Relative Strength Index (RSI)
  • AVTX 80.64
  • ASRV 47.13
  • Support Level
  • AVTX $6.21
  • ASRV $2.64
  • Resistance Level
  • AVTX $6.89
  • ASRV $2.99
  • Average True Range (ATR)
  • AVTX 0.64
  • ASRV 0.16
  • MACD
  • AVTX 0.17
  • ASRV -0.04
  • Stochastic Oscillator
  • AVTX 78.59
  • ASRV 42.65

About AVTX Avalo Therapeutics Inc.

Avalo Therapeutics Inc is a clinical-stage biotechnology company focused on the treatment of immune dysregulation. The company's asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).

About ASRV AmeriServ Financial Inc.

AmeriServ Financial Inc is a bank holding company. The company and its subsidiaries derive substantially all of their income from banking, bank-related services, and trust-related services. Its operating segment includes community banking and it generates maximum revenue. The community banking segment includes both retail and commercial banking activities. The company also offers retail banking which includes the deposit-gathering branch franchise and lending to both individuals and small businesses; Lending activities include residential mortgage loans, direct consumer loans, and small business commercial loans; Commercial banking to businesses includes commercial loans, business services, and CRE loans.

Share on Social Networks: